CAV1 and breast carcinoma: As previous studies have proved that downregulation of CAVIN2 could cause reduction in CAVIN1 and CAV1 expression (54), the interdependency of these 3 molecules makes CAVIN2 as a prominent therapeutic target in breast cancer treatment.